KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Income towards Parent Company (2009 - 2026)

Bristol Myers Squibb (BMY) reported Income towards Parent Company of $2.7 billion for Q1 2026, up 8.81% year-over-year from $2.5 billion in Q1 2025, and up 146.69% on a QoQ basis from $1.1 billion in Q4 2025.

Bristol Myers Squibb (BMY) has 18 years of Income towards Parent Company data on file, last reported at $2.7 billion in Q1 2026.

  • Quarterly Income towards Parent Company rose 8.81% year-over-year to $2.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 billion (up 197.81% YoY) and the FY2025 annual result came in at $7.1 billion, up 178.99% from the prior year.
  • Income towards Parent Company grew to $2.7 billion in Q1 2026 per BMY's latest filing, from $1.1 billion in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $2.7 billion in Q1 2026 and bottomed at -$11.9 billion in Q1 2024.
  • The 5-year median for Income towards Parent Company is $1.6 billion (2024), against an average of $883.5 million.
  • The widest annual swing landed in 2024, when Income towards Parent Company tumbled 625.28%; it then jumped 1328.95% in 2025.
  • Tracing BMY's Income towards Parent Company over 5 years: stood at $2.0 billion in 2022, then dropped by 15.7% to $1.7 billion in 2023, then slumped by 95.55% to $76.0 million in 2024, then jumped by 1328.95% to $1.1 billion in 2025, then jumped by 146.69% to $2.7 billion in 2026.
  • Per Business Quant, the three latest BMY Income towards Parent Company figures stand at $2.7 billion (Q1 2026), $1.1 billion (Q4 2025), and $2.2 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.68 Bn
Dec 31, 2025 1.09 Bn
Sep 30, 2025 2.20 Bn
Jun 30, 2025 1.31 Bn
Mar 31, 2025 2.46 Bn
Dec 31, 2024 76.00 Mn
Sep 30, 2024 1.16 Bn
Jun 30, 2024 1.63 Bn
Mar 31, 2024 -11.91 Bn
Dec 31, 2023 1.71 Bn
Sep 30, 2023 1.93 Bn
Jun 30, 2023 2.08 Bn
Mar 31, 2023 2.27 Bn
Dec 31, 2022 2.03 Bn
Sep 30, 2022 1.61 Bn
Jun 30, 2022 1.43 Bn
Mar 31, 2022 1.28 Bn
Dec 31, 2021 2.37 Bn
Sep 30, 2021 1.48 Bn
Jun 30, 2021 995.00 Mn
Mar 31, 2021 1.96 Bn
Dec 31, 2020 -10.09 Bn
Sep 30, 2020 1.81 Bn
Jun 30, 2020 -146.00 Mn
Mar 31, 2020 -832.00 Mn
Dec 31, 2019 -1.16 Bn
Sep 30, 2019 1.26 Bn
Jun 30, 2019 1.34 Bn
Mar 31, 2019 1.62 Bn
Dec 31, 2018 1.06 Bn
Sep 30, 2018 1.80 Bn
Jun 30, 2018 281.00 Mn
Mar 31, 2018 1.38 Bn
Dec 31, 2017 -2.44 Bn
Sep 30, 2017 725.00 Mn
Jun 30, 2017 800.00 Mn
Mar 31, 2017 1.41 Bn
Dec 31, 2016 728.00 Mn
Sep 30, 2016 1.05 Bn
Jun 30, 2016 1.03 Bn
Mar 31, 2016 1.04 Bn
Dec 31, 2015 -346.00 Mn
Sep 30, 2015 536.00 Mn
Jun 30, 2015 -278.00 Mn
Mar 31, 2015 1.06 Bn
Dec 31, 2014 -104.00 Mn
Sep 30, 2014 674.00 Mn
Jun 30, 2014 282.00 Mn
Mar 31, 2014 878.00 Mn
Dec 31, 2013 653.00 Mn
Sep 30, 2013 704.00 Mn
Jun 30, 2013 528.00 Mn
Mar 31, 2013 583.00 Mn
Dec 31, 2012 909.00 Mn
Sep 30, 2012 -713.00 Mn
Jun 30, 2012 1.09 Bn
Mar 31, 2012 1.48 Bn
Dec 31, 2011 1.32 Bn
Sep 30, 2011 1.36 Bn
Jun 30, 2011 1.31 Bn
Mar 31, 2011 1.37 Bn
Dec 31, 2010 -1.32 Bn
Sep 30, 2010 1.30 Bn
Jun 30, 2010 1.27 Bn
Mar 31, 2010 1.10 Bn
Dec 31, 2009 7.22 Bn
Sep 30, 2009 91.00 Mn
Jun 30, 2009 129.00 Mn
Mar 31, 2009 1.00 Mn